TIMOTHY AUSINK: Open Payments
NPI 1760902365 · YAKIMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,026 in 51 payments from 10 companies in 2025. Trend: 2023 $331 · 2024 $689 · 2025 $1,026
Food & beverage: $1,026
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $361 |
| PFIZER INC. | 18 | $257 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $106 |
| Exact Sciences Corporation | 4 | $81 |
| ABBVIE INC. | 3 | $65 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $54 |
| Novo Nordisk Inc | 2 | $37 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $27 |
| Antares Pharma, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $14 |
Products named: NURTEC ODT, FARXIGA, CAPLYTA, QULIPTA, Cologuard Collection Kit, XIFAXAN, Kerendia, XYOSTED.
Industry payments across WA — which companies pay providers there.
